-
Sex differences in associations of plasma metabolites with blood pressure and heart rate variability: The HELIUS study
Verhaar, B. J. H., Mosterd, C. M., Collard, D., Galenkamp, H., Muller, M., Rampanelli, E., van Raalte, D. H., Nieuwdorp, M. & van den Born, B-J. H., Nov 2023, In: Atherosclerosis. 384, 117147.Research output: Contribution to journal › Article › Academic › peer-review
-
Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
van der Hoek, S., Koomen, J. V., van Bommel, E. J. M., Mosterd, C. M., Scholtes, R. A., Hesp, A. C., Stevens, J., van Raalte, D. H. & Heerspink, H. J. L., 1 May 2023, In: Journal of Personalized Medicine. 13, 5, 747.Research output: Contribution to journal › Article › Academic › peer-review
-
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
Scholtes, R. A., Mosterd, C. M., Hesp, A. C., Smits, M. M., Heerspink, H. J. L. & van Raalte, D. H., Jan 2023, In: Diabetes, Obesity and Metabolism. 25, 1, p. 198-207 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
